IDNA

ETF ticker: NYSE ARCA

PRICE

CHANGE

NET ASSETS

iShares Genomics Immnlgy & Hlthcr ETF (IDNA) Ownership - Who owns iShares Genomics Immnlgy & Hlthcr ETF?

The investment seeks to track the investment results of the NYSE® FactSet® Global Genomics and Immuno Biopharma IndexTM... Show more

Category: #Health

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Details

Group

Domestic Stock Funds

Fundamentals

IDNA

Net Assets

106M

Yield

1.09

Fund Existence

almost 6 years

Total Expense Ratio

0.47

Turnover

51.00

Investment Style

N/A

Capitalization

N/A

Risk (Beta)

1.14

Manager Tenure

N/A

Administrative Fee

N/A

Annual Report Gross Expense Ratio

0.47

Assets in Top Ten Holdings

58.8M

Average Credit Quality

N/A

Average Effective Duration

N/A

Average Effective Maturity

N/A

Fund of Funds

Fund Share Class Net Assets

106M

Fund Type

ETF

Index Fund

Yes

Management Fee

0.47

Modified Duration

N/A

No Load Fund

Yes

Number of Long Holdings

75.00

Number of Net Holdings

80.00

Number of Short Holdings

5.00

Prospectus Acquired Expense Ratio

N/A

Weighting Top Ten Holdings

49.99%

Gain YTD

-10.429

View a ticker or compare two or three

Compare

IDNA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IDNA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for IDNA (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Category Health

Profile

Fundamentals

Details